SB 1442

  • California Senate Bill
  • 2023-2024 Regular Session
  • Introduced in Senate Feb 16, 2024
  • Passed Senate May 22, 2024
  • Assembly
  • Governor

Point-of-care tests for fentanyl.

Abstract

Existing law, the California Affordable Drug Manufacturing Act of 2020, requires the California Health and Human Services Agency (CHHSA) to enter into partnerships, in consultation with other state departments as necessary, to, among other things, increase patient access to affordable drugs. Existing law authorizes CHHSA to enter into partnerships regarding over-the-counter naloxone products for the development, manufacturing, or distribution of those products, as specified. This bill would authorize CHHSA to enter into partnerships for the manufacture or purchase of any United States Food and Drug Administration-approved point-of-care tests for fentanyl to allow for the development, manufacturing, or distribution of those tests by any entity that is authorized to do so under federal or state law.

Bill Sponsors (5)

Votes


Actions


Aug 15, 2024

Assembly

August 15 hearing: Held in committee and under submission.

Jul 02, 2024

Assembly

July 2 set for first hearing. Placed on suspense file.

Jun 26, 2024

Assembly

June 26 hearing postponed by committee.

Jun 13, 2024

Assembly

Read second time and amended. Re-referred to Com. on APPR.

  • Amendment-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on APPR.

Jun 12, 2024

Assembly

From committee: Do pass as amended and re-refer to Com. on APPR. with recommendation: To consent calendar. (Ayes 16. Noes 0.) (June 11).

Jun 03, 2024

Assembly

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

May 23, 2024

Assembly

In Assembly. Read first time. Held at Desk.

May 22, 2024

Senate

Read third time. Passed. (Ayes 38. Noes 0. Page 4135.) Ordered to the Assembly.

May 20, 2024

Senate

Read second time. Ordered to third reading.

May 16, 2024

Senate

Read second time and amended. Ordered to second reading.

Senate

From committee: Do pass as amended. (Ayes 7. Noes 0. Page 3983.) (May 16).

May 10, 2024

Senate

Set for hearing May 16.

Apr 22, 2024

Senate

April 22 hearing: Placed on APPR suspense file.

Apr 12, 2024

Senate

Set for hearing April 22.

Apr 11, 2024

Senate

From committee: Do pass and re-refer to Com. on APPR with recommendation: To consent calendar. (Ayes 11. Noes 0. Page 3562.) (April 10). Re-referred to Com. on APPR.

  • Committee-Passage
  • Committee-Passage-Favorable
  • Referral-Committee
Com. on APPR.

Mar 26, 2024

Senate

Set for hearing April 10.

Mar 18, 2024

Senate

From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.

  • Amendment-Passage
  • Committee-Passage
  • Reading-1
  • Reading-2
  • Referral-Committee
Com. on HEALTH.

Feb 29, 2024

Senate

Referred to Com. on HEALTH.

  • Referral-Committee
Com. on HEALTH.

Feb 20, 2024

Senate

From printer. May be acted upon on or after March 18.

Feb 16, 2024

Senate

Introduced. Read first time. To Com. on RLS. for assignment. To print.

Bill Text

Bill Text Versions Format
SB1442 HTML
02/16/24 - Introduced PDF
03/18/24 - Amended Senate PDF
05/16/24 - Amended Senate PDF
06/13/24 - Amended Assembly PDF

Related Documents

Document Format
04/08/24- Senate Health PDF
04/19/24- Senate Appropriations PDF
05/16/24- Senate Appropriations PDF
05/17/24- Sen. Floor Analyses PDF
06/07/24- Assembly Health PDF
06/28/24- Assembly Appropriations PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the California State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.